Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue

Vaccine. 2010 Nov 29;28(51):8162-8. doi: 10.1016/j.vaccine.2010.09.095. Epub 2010 Oct 27.

Abstract

Antigen presentation by dendritic cells (DC) is of key importance for the initiation of the primary immune response. Mice vaccinated with DC charged with apoptotic/necrotic B16 cells (DC-Apo/Nec) are protected against B16 challenge. The aim of this study was to assess vaccine cell migration in our system and to find out if there is an immunological response taking place at the vaccination site. The formation of a pseudocapsule, peripheral node addresin expression in small venules, and the recruitment of a wide variety of cellular populations, including macrophages, polymorphonuclear lymphocytes, and CD8+ and CD4+ T lymphocytes found in association with DC, evidenced the formation of tertiary lymphoid tissue in the vaccination site in our experimental system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Neoplasm / immunology
  • Cancer Vaccines / administration & dosage
  • Cancer Vaccines / immunology*
  • Dendritic Cells / immunology*
  • Histocytochemistry
  • Injections, Subcutaneous
  • Lymphoid Tissue / physiology*
  • Male
  • Melanoma, Experimental / immunology*
  • Melanoma, Experimental / prevention & control*
  • Mice
  • Mice, Inbred C57BL
  • Subcutaneous Tissue / immunology
  • Survival Analysis
  • Vaccination / methods*

Substances

  • Antigens, Neoplasm
  • Cancer Vaccines